Lung tumor-associated dendritic cell-derived resistin promoted cancer progression by increasing wolf-hirschhorn syndrome candidate 1/twist pathway

Carcinogenesis

Volumn 34, Issue 11, 2013, Pages 2600-2609

  Kuo, Chih Hsin ^a   Chen, Kuei Fang ^a   Chou, Shah Hwa ^b   Huang, Ya Fang ^b,c   Wu, Cheng Ying ^d   Cheng, Da En ^d   Chen, Yu Wen ^b   Yang, Chih Jen ^b,d   Hung, Jen Yu ^b,e   Huang, Ming Shyan ^b,e  

^a NATIONAL KAOHSIUNG NORMAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^d KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^e KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE H3; HISTONE METHYLTRANSFERASE; NEUTRALIZING ANTIBODY; RESISTIN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR TWIST; UNCLASSIFIED DRUG; WOLF HIRSCHHORN SYNDROME CANDIDATE 1 PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CELL DIFFERENTIATION; CELL INVASION; CELL MIGRATION; CLINICAL ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; DNA MODIFICATION; EPIGENETICS; EPITHELIAL MESENCHYMAL TRANSITION; GENE SILENCING; HISTONE METHYLATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG CANCER; METASTASIS; MONOCYTE; MOUSE; NONHUMAN; OSTEOCLASTOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; TUMOR ASSOCIATED DENDRITIC CELL; TUMOR ASSOCIATED LEUKOCYTE; UPREGULATION;

ADENOCARCINOMA; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CARCINOMA, LEWIS LUNG; CASE-CONTROL STUDIES; CELL ADHESION; CELL DIFFERENTIATION; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; CHROMATIN IMMUNOPRECIPITATION; DENDRITIC CELLS; DISEASE PROGRESSION; FLUORESCENT ANTIBODY TECHNIQUE; FOLLOW-UP STUDIES; HISTONE-LYSINE N-METHYLTRANSFERASE; HUMANS; IMMUNOENZYME TECHNIQUES; LUNG NEOPLASMS; MICE; MICE, INBRED C57BL; MONOCYTES; OSTEOCLASTS; REAL-TIME POLYMERASE CHAIN REACTION; REPRESSOR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; TWIST TRANSCRIPTION FACTOR;

EID: 84886998483     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgt281     Document Type: Article

References (41)

1. Demicheli,R. et al. (2012) Recurrence dynamics for non-small-cell lung cancer: effect of surgery on the development of metastases. J. Thorac. Oncol., 7, 723-730.
2. Siegel,R. et al. (2011) Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. Cancer J. Clin., 61, 212-236.
3. Provencio,M. et al. (2010) New molecular targeted therapies integrated with radiation therapy in lung cancer. Clin. Lung Cancer, 11, 91-97.
4. Stossi,F. et al. (2012) Macrophage-elicited loss of estrogen receptor-α in breast cancer cells via involvement of MAPK and c-Jun at the ESR1 genomic locus. Oncogene, 31, 1825-1834.
5. Bayne,L.J. et al. (2012) Tumor-derived granulocyte-macrophage colonystimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer. Cancer Cell, 21, 822-835.
6. Sambandam,Y. et al. (2013) CXCL13 activation of c-Myc induces RANK ligand expression in stromal/preosteoblast cells in the oral squamous cell carcinoma tumor-bone microenvironment. Oncogene, 32, 97-105.
7. Straussman,R. et al. (2012) Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion. Nature, 487, 500-504.
8. Kuo,P.L. et al. (2011) Lung cancer-derived galectin-1 mediates dendritic cell anergy through inhibitor of DNA binding 3/IL-10 signaling pathway. J. Immunol., 186, 1521-1530.
9. Hsu,Y.L. et al. (2011) Lung tumor-associated dendritic cell-derived amphiregulin increased cancer progression. J. Immunol., 187, 1733-1744.
10. Shah,P.P. et al. (2012) PTTG induces EMT through integrin αVβ3-focal adhesion kinase signaling in lung cancer cells. Oncogene, 31, 3124-3135.
11. Rosivatz,E. et al. (2002) Differential expression of the epithelial-mesenchymal transition regulators snail, SIP1, and twist in gastric cancer. Am. J. Pathol., 161, 1881-1891.
12. Merikallio,H. et al. (2011) Zeb1 and twist are more commonly expressed in metastatic than primary lung tumours and show inverse associations with claudins. J. Clin. Pathol., 64, 136-140.
13. Thathia,S.H. et al. (2012) Epigenetic inactivation of TWIST2 in acute lymphoblastic leukemia modulates proliferation, cell survival and chemosensitivity. Haematologica, 97, 371-378.
14. Ezponda,T. et al. (2013) The histone methyltransferase MMSET/WHSC1 activates TWIST1 to promote an epithelial-mesenchymal transition and invasive properties of prostate cancer. Oncogene, 32, 2882-2890.
15. Katto,J. et al. (2011) Epigenetic regulation of cellular adhesion in cancer. Carcinogenesis, 32, 1414-1418.
16. Vakoc,C.R. et al. (2006) Profile of histone lysine methylation across transcribed mammalian chromatin. Mol. Cell. Biol., 26, 9185-9195.
17. Steppan,C.M. et al. (2001) The hormone resistin links obesity to diabetes. Nature, 409, 307-312.
18. Tiaka,E.K. et al. (2011) The implication of adiponectin and resistin in gastrointestinal diseases. Cytokine Growth Factor Rev., 22, 109-119.
19. Filková,M. et al. (2012) Resistin in idiopathic inflammatory myopathies. Arthritis Res. Ther., 14, R111.
20. Zhang,J. et al. (2010) Resistin up-regulates COX-2 expression via TAK1-IKK-NF-kappaB signaling pathway. Inflammation, 33, 25-33.
21. Landvik,N.E. et al. (2009) A specific interleukin-1B haplotype correlates with high levels of IL1B mRNA in the lung and increased risk of non-small cell lung cancer. Carcinogenesis, 30, 1186-1192.
22. Sǎlǎgeanu,A. et al. (2010) Serum levels of adipokines resistin and leptin in patients with colon cancer. J. Med. Life, 3, 416-420.
23. Nakajima,T.E. et al. (2009) Adipocytokine levels in gastric cancer patients: resistin and visfatin as biomarkers of gastric cancer. J. Gastroenterol., 44, 685-690.
24. Karapanagiotou,E.M. et al. (2008) The significance of leptin, adiponectin, and resistin serum levels in non-small cell lung cancer (NSCLC). Lung Cancer, 61, 391-397.
25. Chu,Y.W. et al. (1997) Selection of invasive and metastatic subpopulations from a human lung adenocarcinoma cell line. Am. J. Respir. Cell Mol. Biol., 17, 353-360.
26. Yao,P.L. et al. (2005) Autocrine and paracrine regulation of interleukin-8 expression in lung cancer cells. Am. J. Respir. Cell Mol. Biol., 32, 540-547.
27. Kuo,P.L. et al. (2012) Lung cancer-derived galectin-1 enhances tumorigenic potentiation of tumor-associated dendritic cells by expressing heparin-binding EGF-like growth factor. J. Biol. Chem., 287, 9753-9764.
28. Toyokawa,G. et al. (2011) Histone lysine methyltransferase Wolf-Hirschhorn syndrome candidate 1 is involved in human carcinogenesis through regulation of the Wnt pathway. Neoplasia, 13, 887-898.
29. Turk,F. et al. (2011) Comparison of clinical and pathological tumor, node and metastasis staging of lung cancer: 15-year experience with 530 patients. Minerva Chir., 66, 509-516.
30. McTernan,C.L. et al. (2002) Resistin, central obesity, and type 2 diabetes. Lancet, 359, 46-47.
31. Kim,H.J. et al. (2011) Expression of resistin in the prostate and its stimulatory effect on prostate cancer cell proliferation. BJU Int., 108(2 Pt 2), E77-E83.
32. Conde,J. et al. (2011) Adipokines: biofactors from white adipose tissue. A complex hub among inflammation, metabolism, and immunity. Biofactors, 37, 413-420.
33. Di Simone,N. et al. (2006) Resistin regulates human choriocarcinoma cell invasive behaviour and endothelial cell angiogenic processes. J. Endocrinol., 189, 691-699.
34. Yang,J. et al. (2004) Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell, 117, 927-939.
35. Bloch-Zupan,A. et al. (2001) R-twist gene expression during rat palatogenesis. Int. J. Dev. Biol., 45, 397-404.
36. Fu,J. et al. (2011) The TWIST/Mi2/NuRD protein complex and its essential role in cancer metastasis. Cell Res., 21, 275-289.
37. Stec,I. et al. (1998) WHSC1, a 90 kb SET domain-containing gene, expressed in early development and homologous to a Drosophila dysmorphy gene maps in the Wolf-Hirschhorn syndrome critical region and is fused to IgH in t(4;14) multiple myeloma. Hum. Mol. Genet., 7, 1071-1082.
38. Sharathkumar,A. et al. (2003) Malignant hematological disorders in children with Wolf-Hirschhorn syndrome. Am. J. Med. Genet. A, 119A, 194-199.
39. Xu,C.R. et al. (2008) Reciprocal patterns of methylation of H3K36 and H3K27 on proximal vs. distal IgVH genes are modulated by IL-7 and Pax5. Proc. Natl Acad. Sci. USA, 105, 8685-8690.
40. Nimura,K. et al. (2009) A histone H3 lysine 36 trimethyltransferase links Nkx2-5 to Wolf-Hirschhorn syndrome. Nature, 460, 287-291.
41. Yang,P. et al. (2012) Histone methyltransferase NSD2/MMSET mediates constitutive NF-κB signaling for cancer cell proliferation, survival, and tumor growth via a feed-forward loop. Mol. Cell. Biol., 32, 3121-3131.